To the best of our knowledge, this is the first study to present a comprehensive real‐world investigation into the prophylactic application of long‐acting G‐CSF for addressing chemotherapy‐induced neutropenia in patients with gastrointestinal cancer. This evidence concerns the gene CSF3 and Decreased total neutrophil count.